VT News

Jim McCourt

Ask VT AI
View News Summary
  • Analysts warn investors to look beyond short-term momentum and focus on improving unit trends, healthy margins, and sustainable cash generation when evaluating U.S. stocks.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Red Bull fined €50,000 for grid-tape interference, highlighting a procedural lapse that did not affect the race result.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Analysts warn investors to look beyond short-term momentum and focus on improving unit trends, healthy margins, and sustainable cash generation when evaluating U.S. stocks.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Red Bull fined €50,000 for grid-tape interference, highlighting a procedural lapse that did not affect the race result.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jim McCourt

Top Topics

Trending in U.S.

World

Sport